Masitinib by AB Science has curbed cognitive deterioration in Alzheimer-type dementia. And that’s a new hope.
dementia
Posted inClinical Trials, Neuroscience
Donanemab: Possible Treatment for Alzheimer’s Disease
The amyloid hypothesis, being verified by Eli Lilly, is not about to go away. However, the therapeutic achievements are still quite modest.